Published: March 21, 2022, 7 a.m.
We tackle the complexities of pain management in patients with chronic kidney disease in this reboot from @NephMadness 2019 that, on a scale of 1-10, will leave you feeling very relieved in addressing pain. Topics: Opioids, gabapentinoids, NSAIDS, pain ladders, why tramadol is tramadont, and more!\n
\n\n\nEpisodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!\n\n\n
\nCredits\n
\n- Written and produced by: Justin Berk MD
\n- NephMadness Pain Region: Samantha Gelfand MD
\n- NephMadness Pun Contest produced by: Hannah R Abrams
\n- Cover art by: Kate Grant MBChB, Dip GUMed
\n- Hosts: Matthew Watto MD, Paul Williams MD, Stuart Brigham MD
\n- Edited by: Matthew Watto MD (audio), Emi Okamoto MD (show notes)
\n- Guests:\xa0 Samantha Gelfand MD, Matthew Sparks MD, David Juurlink MD
\n
\n\n
\nShow Segments\n
\n- Kidney Pun
\n- Disclaimer, intro and guest bios
\n- Guest one-liners
\n- Clinical Case and Pain Management Disclaimer
\n- Modalities for pain meds in ckd
\n- Opioids for pain and their metabolites
\n- Dave Juurlink reframes the question, \u201cwhat is our real goal with pain management?\u201d
\n- Matt Sparks reiterates the dangers of morphine and codeine in patients with advanced CKD
\n- Communicating meds that are contraindicated or relatively contraindicated in CKD
\n- Buprenorphine
\n- What about the WHO Pain Ladder for CKD?
\n- Should we use more cannabinoids? Ketamine?
\n- Dave Juurlink rants on Tramadol
\n- NSAIDS and CKD
\n- Gabapentinoids (gabapentin and pregabalin) for neuropathic pain and driving?!
\n- Estimating eGFR in CKD and AKI. Which equation is best?
\n- How would each of our experts treat this patient with CKD and knee pain
\n- Outro
\n
\n
\n\n\n
\nSponsors:\xa0\n
\n\n
\n
\n\n